This is a review for the USMLE Step 1 of Pathology. It contains anything you need to know for your exam in pictures, diagrams and tables. THIS IS A TWO PART SERIES, look for the first part.
This document discusses pediatric cardiology emergencies, dividing them into newborn emergencies and infant/childhood emergencies. Newborn emergencies include cyanosis caused by obstructive lesions like pulmonary atresia or abnormal circulations like transposition of the great arteries, treated with prostaglandins. Low cardiac output in newborns can be caused by left-sided obstructive lesions, muscle diseases, or heart rate problems and is treated with inotropes and afterload reduction. Infant/childhood emergencies include hypercyanotic spells in conditions like tetralogy of Fallot, congestive heart failure with different causes at different ages, and arrhythmias including supraventricular tachy
This document provides information on heart failure (CHF), including:
1) CHF is a clinical syndrome that results from any structural or functional cardiac disorder that impairs the ventricle's ability to fill or eject blood.
2) The main mechanisms of CHF are increased blood volume, increased resistance to blood flow, decreased contractility, and decreased filling.
3) CHF can be compensated initially through mechanisms like the Frank-Starling mechanism and neurohormonal activation, but these can eventually worsen heart failure.
Congestive heart failure (CHF) results from any structural or functional cardiac disorder that impairs the ventricle's ability to fill with or eject blood. It is diagnosed based on history, physical exam, chest x-ray, EKG, and echocardiogram. Treatment focuses on restoring normal cardiopulmonary physiology by using ACE inhibitors, beta-blockers, diuretics, and addressing pulmonary complications. Management involves evaluating the patient's stage of CHF and functional classification to determine appropriate pharmacotherapy and monitoring according to guidelines from the American Heart Association.
2022 Guideline for the Management of Heart Failure Clinical Update.pptxsubhankar16
This document summarizes guidelines from the 2022 AHA/ACC/HFSA for the diagnosis and management of heart failure. It defines the stages of heart failure from A to D and discusses evaluation, causes, biomarkers, imaging, and invasive testing. Key recommendations include using biomarkers like BNP and NT-proBNP to diagnose and manage HF. Transthoracic echocardiography is recommended for initial evaluation, and cardiac MRI, CT, or nuclear imaging if echo is inadequate. Invasive procedures are not routinely recommended but may help in select cases. Remote monitoring can benefit some patients with advanced HF.
This document discusses pediatric cardiology emergencies, dividing them into newborn emergencies and infant/childhood emergencies. Newborn emergencies include cyanosis caused by obstructive lesions like pulmonary atresia or abnormal circulations like transposition of the great arteries, treated with prostaglandins. Low cardiac output in newborns can be caused by left-sided obstructive lesions, muscle diseases, or heart rate problems and is treated with inotropes and afterload reduction. Infant/childhood emergencies include hypercyanotic spells in conditions like tetralogy of Fallot, congestive heart failure with different causes at different ages, and arrhythmias including supraventricular tachy
This document provides information on heart failure (CHF), including:
1) CHF is a clinical syndrome that results from any structural or functional cardiac disorder that impairs the ventricle's ability to fill or eject blood.
2) The main mechanisms of CHF are increased blood volume, increased resistance to blood flow, decreased contractility, and decreased filling.
3) CHF can be compensated initially through mechanisms like the Frank-Starling mechanism and neurohormonal activation, but these can eventually worsen heart failure.
Congestive heart failure (CHF) results from any structural or functional cardiac disorder that impairs the ventricle's ability to fill with or eject blood. It is diagnosed based on history, physical exam, chest x-ray, EKG, and echocardiogram. Treatment focuses on restoring normal cardiopulmonary physiology by using ACE inhibitors, beta-blockers, diuretics, and addressing pulmonary complications. Management involves evaluating the patient's stage of CHF and functional classification to determine appropriate pharmacotherapy and monitoring according to guidelines from the American Heart Association.
2022 Guideline for the Management of Heart Failure Clinical Update.pptxsubhankar16
This document summarizes guidelines from the 2022 AHA/ACC/HFSA for the diagnosis and management of heart failure. It defines the stages of heart failure from A to D and discusses evaluation, causes, biomarkers, imaging, and invasive testing. Key recommendations include using biomarkers like BNP and NT-proBNP to diagnose and manage HF. Transthoracic echocardiography is recommended for initial evaluation, and cardiac MRI, CT, or nuclear imaging if echo is inadequate. Invasive procedures are not routinely recommended but may help in select cases. Remote monitoring can benefit some patients with advanced HF.
The document discusses congestive cardiac failure (heart failure) and its management. It provides details on:
- The high prevalence and mortality of heart failure.
- Current medical therapies including ACE inhibitors, beta-blockers, and aldosterone antagonists that have been shown to improve survival.
- Device therapies like cardiac resynchronization therapy and implantable cardioverter defibrillators that treat symptoms and reduce mortality.
- The benefits of multidisciplinary and integrated care approaches including telehealth monitoring in improving outcomes for heart failure patients.
Cardiac arrhythmias are abnormalities in the heart's rhythm. There are two main types: bradycardia, a slow heart rate, and tachycardia, a fast heart rate. Various arrhythmias are described including sinus bradycardia, heart block, atrial fibrillation, atrial flutter, AV nodal reentry tachycardia, ventricular fibrillation, and ventricular tachycardia. Treatment depends on the type of arrhythmia and may include medication, cardioversion, ablation, or pacemaker implantation. Diagnosis involves ECG, echocardiogram, blood tests, and other cardiac tests. Lifestyle changes and avoiding arrhythmia triggers can help management.
This student "cheat sheet" is designed to provide medical students with basic information regarding the diagnosis and treatment of type 2 DM. It includes Questions to Ask, what to look for on a Physical Exam, Labs to Order, and basic Treatment Plans.
These guides are particularly designed for first and second-year medical students as an introduction to ambulatory care medicine and attempts to tie in the basic pathophysiology that is high-yield for USMLE Step 1.
Any and all feedback is very welcomed.
This document discusses the management of atrial fibrillation (AF). It outlines the goals of management which are to prevent stroke, cardiomyopathy, relieve symptoms, and improve survival. The main strategies for management are rate control, rhythm control, and prevention of thromboembolism. Rate control is recommended for all AF patients using medications, while rhythm control is only recommended for selected patients. Risk stratification is important for determining anticoagulation and cardioversion approaches. Electrical and pharmacological cardioversion can be used to restore normal sinus rhythm but have varying success rates depending on the duration and chronicity of AF.
Heart failure is a condition where the heart cannot pump enough blood to meet the body's needs. It affects over 5 million Americans. The prevalence increases with age, reaching nearly 10% in those over 80. Symptoms include fatigue, shortness of breath, swelling, and more. Treatment focuses on reducing cardiac workload through diuretics, beta blockers, ACE inhibitors, and other drugs. Device therapies like CRT can also help certain patients. Lifestyle changes and strict medication adherence are important for managing the condition.
This document provides several mnemonics to aid in remembering cardiology concepts. It lists mnemonics for syncope causes (VASOVAGALS and THIS-MADE-ME-DAMN-VAGAL), arrhythmia causes (ACID-ME), atrial fibrillation causes (I-HAVE-A-FIB), congestive heart failure causes (ISCHEMIA-PA-CATHS and EDEMA-TOES), hypotension causes (BP-DECLINED), pericarditis causes (PR-DIP-ST-UP and IT-CAUSED-PERICARDITIS), and restrictive cardiac disease causes (A-STIFFER-CHF).
The document provides clues for various medical topics in a question-and-answer format. It includes clues about bacteria, diseases, drugs, enzymes, vaccines, HLA antigens, laboratory values, pathologies, and other topics. The clues are in the form of short phrases, acronyms, or word patterns to help remember key information.
Heart failure is a common and serious condition where the heart muscle is unable to pump sufficiently. It can have multiple causes and the prevalence increases significantly with age. Prognosis remains poor with high mortality rates. Diagnosis involves evaluating symptoms, signs, and testing like echocardiogram. Management focuses on general measures like diet, exercise, and reducing risk factors as well as specific treatments targeting the underlying cause and physiology of heart failure.
Update in HF Definition and Classification: Universal Definition and Stages o...Duke Heart
1. The document presents an overview of Biykem Bozkurt, an expert in heart failure, and their work updating the definition and classification of heart failure.
2. The Universal Definition of Heart Failure (UDHF) defines heart failure as a clinical syndrome with current or prior symptoms and/or signs caused by structural and/or functional cardiac abnormalities, as corroborated by elevated natriuretic peptide levels or objective evidence of congestion.
3. The UDHF also establishes a classification system with Stages A through D based on risk, presence of structural heart disease, and severity of symptoms, to help guide treatment strategies according to the stage of heart failure.
Anemia can be caused by decreased red blood cell production, blood loss, or red blood cell destruction. The document outlines various etiologies for each category including deficiencies in iron, B12, or folate, blood loss, bone marrow suppression, and intrinsic or extrinsic red blood cell defects. A thorough workup involves considering the complete blood count, blood smear, iron studies, and bone marrow examination to help determine the cause and guide treatment.
Arrhythmias refer to abnormalities in the cardiac rhythm. There are two main types: bradycardia where the heart rate is slow, and tachycardia where the heart rate is fast. Specific arrhythmias include sinus bradycardia, various types of heart block, atrial fibrillation, atrial flutter, AV nodal re-entry tachycardia, ventricular tachycardia, and ventricular fibrillation. Diagnosis involves electrocardiography and other tests. Treatment depends on the type of arrhythmia but may include medications, catheter ablation, pacemaker implantation, or cardioversion. Lifestyle modifications and avoiding arrhythmia triggers can also help management.
This document contains mnemonics and summaries to aid in remembering various concepts in cardiology. It includes summaries of aortic stenosis characteristics, management of myocardial infarction, causes of pericarditis, heart compensatory mechanisms, distinguishing right and left heart murmurs, causes of ST elevation on ECG, Beck's triad signs, and treatment for myocardial infarction. It also includes mnemonics for jugular venous pressure causes, depressed ST-segment causes, innocent murmur features, murmur locations, cardioselective betablockers, and more.
The document discusses acute coronary syndrome (ACS), which includes unstable angina, ST elevation myocardial infarction (STEMI), and non-ST elevation myocardial infarction (NSTEMI). ACS is characterized by new or worsening chest pain or discomfort due to reduced blood flow in the coronary arteries. The main causes are atherosclerotic plaque rupture and thrombosis formation, which can completely or partially block blood flow. Investigation and management involves ECG, cardiac biomarkers, risk stratification scores, antiplatelet and anticoagulant therapy, and often coronary angiography.
This document discusses the classification, symptoms, and treatment of heart failure. It begins by classifying heart failure based on its onset (acute or chronic), which side of the heart is affected (left or right), and its severity according to the New York Heart Association stages. The main symptoms of heart failure are then described using the mnemonic "FACES" (fatigue, activities limited, chest congestion, edema, shortness of breath). The document goes on to outline pharmacological treatments including ACE inhibitors, beta blockers, spironolactone, diuretics, and digoxin. Non-pharmacological interventions like diet, exercise, and cardiac rehabilitation are also mentioned.
This document discusses the diagnosis and investigation of secondary hypertension. It describes various reversible and irreversible causes of secondary hypertension including renal, endocrine, vascular, and drug-related factors. It provides guidance on screening investigations including plasma and urine tests. It also outlines specialized tests that may be used to investigate particular causes such as renal artery stenosis, Conn's syndrome, phaeochromocytoma, and renal artery stenosis. These involve tests such as renal artery duplex ultrasound, CT/MRI scans, renal vein sampling, and MIBG scans.
R.M., a 35-year-old male, presented with sudden onset of dizziness, vomiting, left-sided weakness, slurred speech, and loss of coordination on the left side. His neurological exam showed signs consistent with a right pontine cerebellar stroke, including lateral rectus palsy and facial droop on the left side. Imaging revealed an old infarct in the right cerebellar hemisphere. The patient's risk factors included a family history of cardiovascular disease and a 25 pack-year smoking history. He was diagnosed with a stroke in the young, likely due to thrombotic occlusion from underlying vascular risk factors.
This document discusses the classification, evaluation, and management of hypertensive crises. It defines hypertensive emergency as severe hypertension with acute end-organ damage requiring immediate treatment to lower blood pressure, while hypertensive urgency involves severe hypertension without end-organ damage that usually allows for gradual blood pressure reduction over 24-48 hours. It provides guidelines for initial evaluation, laboratory testing, goals of therapy, recommended antihypertensive agents, and dosing for treating different types of hypertensive crises.
This document provides information on various types of cardiomyopathy and myocarditis. It discusses the causes, clinical features, diagnostic evaluation and management of conditions such as hypertrophic cardiomyopathy, dilated cardiomyopathy, restrictive cardiomyopathy, left ventricular noncompaction, arrhythmogenic right ventricular cardiomyopathy, endocardial fibroelastosis, and myocarditis. The document contains detailed information on the pathogenesis, clinical presentation, investigations including echocardiography, MRI and endomyocardial biopsy, and treatment of these conditions.
This document discusses various types of heart disease including hypertensive heart disease, cardiomyopathies, valvular heart disease, and infective endocarditis. It provides details on the criteria, morphology, causes, and clinical features of each condition. Specifically, it describes how hypertensive heart disease can cause left or right ventricular hypertrophy and heart failure. It also explains the differences between dilated, hypertrophic, and restrictive cardiomyopathies and their causes and features.
The document discusses congestive cardiac failure (heart failure) and its management. It provides details on:
- The high prevalence and mortality of heart failure.
- Current medical therapies including ACE inhibitors, beta-blockers, and aldosterone antagonists that have been shown to improve survival.
- Device therapies like cardiac resynchronization therapy and implantable cardioverter defibrillators that treat symptoms and reduce mortality.
- The benefits of multidisciplinary and integrated care approaches including telehealth monitoring in improving outcomes for heart failure patients.
Cardiac arrhythmias are abnormalities in the heart's rhythm. There are two main types: bradycardia, a slow heart rate, and tachycardia, a fast heart rate. Various arrhythmias are described including sinus bradycardia, heart block, atrial fibrillation, atrial flutter, AV nodal reentry tachycardia, ventricular fibrillation, and ventricular tachycardia. Treatment depends on the type of arrhythmia and may include medication, cardioversion, ablation, or pacemaker implantation. Diagnosis involves ECG, echocardiogram, blood tests, and other cardiac tests. Lifestyle changes and avoiding arrhythmia triggers can help management.
This student "cheat sheet" is designed to provide medical students with basic information regarding the diagnosis and treatment of type 2 DM. It includes Questions to Ask, what to look for on a Physical Exam, Labs to Order, and basic Treatment Plans.
These guides are particularly designed for first and second-year medical students as an introduction to ambulatory care medicine and attempts to tie in the basic pathophysiology that is high-yield for USMLE Step 1.
Any and all feedback is very welcomed.
This document discusses the management of atrial fibrillation (AF). It outlines the goals of management which are to prevent stroke, cardiomyopathy, relieve symptoms, and improve survival. The main strategies for management are rate control, rhythm control, and prevention of thromboembolism. Rate control is recommended for all AF patients using medications, while rhythm control is only recommended for selected patients. Risk stratification is important for determining anticoagulation and cardioversion approaches. Electrical and pharmacological cardioversion can be used to restore normal sinus rhythm but have varying success rates depending on the duration and chronicity of AF.
Heart failure is a condition where the heart cannot pump enough blood to meet the body's needs. It affects over 5 million Americans. The prevalence increases with age, reaching nearly 10% in those over 80. Symptoms include fatigue, shortness of breath, swelling, and more. Treatment focuses on reducing cardiac workload through diuretics, beta blockers, ACE inhibitors, and other drugs. Device therapies like CRT can also help certain patients. Lifestyle changes and strict medication adherence are important for managing the condition.
This document provides several mnemonics to aid in remembering cardiology concepts. It lists mnemonics for syncope causes (VASOVAGALS and THIS-MADE-ME-DAMN-VAGAL), arrhythmia causes (ACID-ME), atrial fibrillation causes (I-HAVE-A-FIB), congestive heart failure causes (ISCHEMIA-PA-CATHS and EDEMA-TOES), hypotension causes (BP-DECLINED), pericarditis causes (PR-DIP-ST-UP and IT-CAUSED-PERICARDITIS), and restrictive cardiac disease causes (A-STIFFER-CHF).
The document provides clues for various medical topics in a question-and-answer format. It includes clues about bacteria, diseases, drugs, enzymes, vaccines, HLA antigens, laboratory values, pathologies, and other topics. The clues are in the form of short phrases, acronyms, or word patterns to help remember key information.
Heart failure is a common and serious condition where the heart muscle is unable to pump sufficiently. It can have multiple causes and the prevalence increases significantly with age. Prognosis remains poor with high mortality rates. Diagnosis involves evaluating symptoms, signs, and testing like echocardiogram. Management focuses on general measures like diet, exercise, and reducing risk factors as well as specific treatments targeting the underlying cause and physiology of heart failure.
Update in HF Definition and Classification: Universal Definition and Stages o...Duke Heart
1. The document presents an overview of Biykem Bozkurt, an expert in heart failure, and their work updating the definition and classification of heart failure.
2. The Universal Definition of Heart Failure (UDHF) defines heart failure as a clinical syndrome with current or prior symptoms and/or signs caused by structural and/or functional cardiac abnormalities, as corroborated by elevated natriuretic peptide levels or objective evidence of congestion.
3. The UDHF also establishes a classification system with Stages A through D based on risk, presence of structural heart disease, and severity of symptoms, to help guide treatment strategies according to the stage of heart failure.
Anemia can be caused by decreased red blood cell production, blood loss, or red blood cell destruction. The document outlines various etiologies for each category including deficiencies in iron, B12, or folate, blood loss, bone marrow suppression, and intrinsic or extrinsic red blood cell defects. A thorough workup involves considering the complete blood count, blood smear, iron studies, and bone marrow examination to help determine the cause and guide treatment.
Arrhythmias refer to abnormalities in the cardiac rhythm. There are two main types: bradycardia where the heart rate is slow, and tachycardia where the heart rate is fast. Specific arrhythmias include sinus bradycardia, various types of heart block, atrial fibrillation, atrial flutter, AV nodal re-entry tachycardia, ventricular tachycardia, and ventricular fibrillation. Diagnosis involves electrocardiography and other tests. Treatment depends on the type of arrhythmia but may include medications, catheter ablation, pacemaker implantation, or cardioversion. Lifestyle modifications and avoiding arrhythmia triggers can also help management.
This document contains mnemonics and summaries to aid in remembering various concepts in cardiology. It includes summaries of aortic stenosis characteristics, management of myocardial infarction, causes of pericarditis, heart compensatory mechanisms, distinguishing right and left heart murmurs, causes of ST elevation on ECG, Beck's triad signs, and treatment for myocardial infarction. It also includes mnemonics for jugular venous pressure causes, depressed ST-segment causes, innocent murmur features, murmur locations, cardioselective betablockers, and more.
The document discusses acute coronary syndrome (ACS), which includes unstable angina, ST elevation myocardial infarction (STEMI), and non-ST elevation myocardial infarction (NSTEMI). ACS is characterized by new or worsening chest pain or discomfort due to reduced blood flow in the coronary arteries. The main causes are atherosclerotic plaque rupture and thrombosis formation, which can completely or partially block blood flow. Investigation and management involves ECG, cardiac biomarkers, risk stratification scores, antiplatelet and anticoagulant therapy, and often coronary angiography.
This document discusses the classification, symptoms, and treatment of heart failure. It begins by classifying heart failure based on its onset (acute or chronic), which side of the heart is affected (left or right), and its severity according to the New York Heart Association stages. The main symptoms of heart failure are then described using the mnemonic "FACES" (fatigue, activities limited, chest congestion, edema, shortness of breath). The document goes on to outline pharmacological treatments including ACE inhibitors, beta blockers, spironolactone, diuretics, and digoxin. Non-pharmacological interventions like diet, exercise, and cardiac rehabilitation are also mentioned.
This document discusses the diagnosis and investigation of secondary hypertension. It describes various reversible and irreversible causes of secondary hypertension including renal, endocrine, vascular, and drug-related factors. It provides guidance on screening investigations including plasma and urine tests. It also outlines specialized tests that may be used to investigate particular causes such as renal artery stenosis, Conn's syndrome, phaeochromocytoma, and renal artery stenosis. These involve tests such as renal artery duplex ultrasound, CT/MRI scans, renal vein sampling, and MIBG scans.
R.M., a 35-year-old male, presented with sudden onset of dizziness, vomiting, left-sided weakness, slurred speech, and loss of coordination on the left side. His neurological exam showed signs consistent with a right pontine cerebellar stroke, including lateral rectus palsy and facial droop on the left side. Imaging revealed an old infarct in the right cerebellar hemisphere. The patient's risk factors included a family history of cardiovascular disease and a 25 pack-year smoking history. He was diagnosed with a stroke in the young, likely due to thrombotic occlusion from underlying vascular risk factors.
This document discusses the classification, evaluation, and management of hypertensive crises. It defines hypertensive emergency as severe hypertension with acute end-organ damage requiring immediate treatment to lower blood pressure, while hypertensive urgency involves severe hypertension without end-organ damage that usually allows for gradual blood pressure reduction over 24-48 hours. It provides guidelines for initial evaluation, laboratory testing, goals of therapy, recommended antihypertensive agents, and dosing for treating different types of hypertensive crises.
This document provides information on various types of cardiomyopathy and myocarditis. It discusses the causes, clinical features, diagnostic evaluation and management of conditions such as hypertrophic cardiomyopathy, dilated cardiomyopathy, restrictive cardiomyopathy, left ventricular noncompaction, arrhythmogenic right ventricular cardiomyopathy, endocardial fibroelastosis, and myocarditis. The document contains detailed information on the pathogenesis, clinical presentation, investigations including echocardiography, MRI and endomyocardial biopsy, and treatment of these conditions.
This document discusses various types of heart disease including hypertensive heart disease, cardiomyopathies, valvular heart disease, and infective endocarditis. It provides details on the criteria, morphology, causes, and clinical features of each condition. Specifically, it describes how hypertensive heart disease can cause left or right ventricular hypertrophy and heart failure. It also explains the differences between dilated, hypertrophic, and restrictive cardiomyopathies and their causes and features.
This document discusses pulmonary embolism (PE), which occurs when a blood clot breaks off and travels to the lungs. It defines PE and classifies the severity. Risk factors include prolonged bed rest, surgery, cancer, and inherited or acquired hypercoagulable states. Symptoms are often nonspecific but include chest pain and difficulty breathing. PE is caused by deep vein thrombosis (DVT) in the legs traveling to the lungs. The diagnosis is challenging due to vague symptoms but is important because untreated PE can be fatal.
This document provides an overview of cardiomyopathy, focusing on its three main types: dilated cardiomyopathy, hypertrophic cardiomyopathy, and restrictive cardiomyopathy. It defines cardiomyopathy as a disease of the heart muscle not caused by other structural heart issues. For each type, it discusses presentation, causes, morphology, clinical features, investigations and management. Dilated cardiomyopathy involves an enlarged heart with reduced function, while hypertrophic cardiomyopathy features abnormal thickening and restrictive cardiomyopathy impaired diastolic function. The document presents detailed information on evaluating and treating each form of cardiomyopathy.
AML is characterized by accumulation of abnormal blast cells in the bone marrow and impaired production of normal blood cells. It results from clonal expansion of myeloid precursor cells with reduced ability to differentiate. Treatment involves induction chemotherapy with anthracyclines and cytarabine to achieve complete remission, defined as less than 5% blasts in the bone marrow. Risk is then assessed based on genetics to determine if additional chemotherapy or stem cell transplant is needed.
This document discusses different types of cardiomyopathy, including dilated cardiomyopathy (DCM), hypertrophic cardiomyopathy (HCM), and restrictive cardiomyopathy. DCM is characterized by enlarged heart chambers and reduced systolic function. HCM involves thickened heart muscle and potential outflow tract obstruction. Restrictive cardiomyopathy restricts heart filling due to stiff heart muscles. The causes, clinical presentations, diagnostic evaluations, and management strategies are described for each type of cardiomyopathy.
presentation on CHF,orchitis,shock,anemiaRoshan paudel
This document provides information on various types of shock, congestive heart failure, anaemia, and orchitis. It discusses the etiology, pathophysiology, clinical signs, diagnosis, and management of each condition. The main types of shock described are hypovolemic, cardiogenic, and distributive shock. Congestive heart failure results from the heart's inability to pump sufficiently. The signs of left and right sided heart failure are outlined. Anaemia is classified based on red blood cell morphology and causes. Orchitis is testicular inflammation that can result from infection, trauma, or parasites.
This document discusses edema, including its definition, pathophysiology, common causes, and approaches to diagnosis and management. Edema is caused by increased hydrostatic pressure, decreased colloid osmotic pressure, or increased capillary permeability. Common causes include heart failure, cirrhosis, nephrotic syndrome, and pregnancy. The case scenario describes a patient with fatigue, swelling, and liver enlargement, suggesting heart failure as the most likely diagnosis. Diagnostic testing may include chest x-rays, echocardiograms, and lab tests. Treatment involves reversing the underlying cause, restricting dietary sodium, and using diuretic medications.
The document discusses edema and fluid balance in the body. It describes the normal circulation of fluid between blood and tissues, mediated by hydrostatic and oncotic pressures. Edema occurs when there is increased hydrostatic pressure, decreased oncotic pressure, increased capillary permeability, or impaired lymphatic drainage. Specific types of edema discussed include cardiac, hepatic, pulmonary, cerebral, and lymphatic edema. Sites of common edema and clinical significance are also reviewed.
This document discusses hypertension (high blood pressure) and its pathogenesis. It notes that hypertension is defined as a sustained systolic pressure over 140 mmHg or diastolic pressure over 90 mmHg. While the causes are often unknown, hypertension can lead to heart disease, stroke, and kidney failure if left untreated. The document outlines different types of secondary hypertension and vascular changes seen in hypertensive patients.
This document provides an overview of venous thromboembolism (VTE). It discusses the pathophysiology of blood clot formation, risk factors for VTE, signs and symptoms of deep vein thrombosis (DVT) and pulmonary embolism (PE), diagnostic tests, and goals of treatment. The optimal management of VTE involves preventing both short-term complications like clot propagation and long-term issues such as post-thrombotic syndrome through the use of anticoagulation therapies like unfractionated heparin and low molecular weight heparins.
This document discusses the pathophysiology of myocardial ischemia and infarction. It describes how myocardial oxygen demand can exceed supply, leading to ischemia. Factors that determine oxygen demand and supply are explored, including heart rate, contractility, wall tension, coronary blood flow, oxygen carrying capacity of blood, and autoregulatory resistance in arterioles. The progression and vulnerability of atherosclerotic plaque is summarized. Clinical syndromes like stable angina and acute coronary syndromes (unstable angina and myocardial infarction) are defined and their presentations, diagnoses, and treatment approaches are overviewed.
ISCHEMIA HEART DISEASE AND MYOCARDIAL INFARETIONfikri asyura
This document discusses ischemic heart disease and myocardial infarction. It covers the pathophysiology of coronary ischemia, including how myocardial oxygen demand and supply are determined. When demand exceeds supply, ischemia occurs. The document details the physiology of coronary blood flow, autoregulation, and flow reserve. It then covers the clinical syndromes of stable angina, unstable angina, and acute myocardial infarction. Key concepts include the progression of atherosclerotic plaque, the vulnerable plaque that can rupture in acute coronary syndromes, and the treatment approaches for stable and unstable ischemia.
Ischemic colitis is the most common form of intestinal ischemia. It manifests as a spectrum of injury from transient self-limited ischemia involving the mucosa and submucosa to acute fulminant ischemia with transmural infarction that may progress to necrosis and death. Although there are a variety of causes, the most common mechanism is an acute, self-limited compromise in intestinal blood flow.
This document discusses the etiopathogenesis and management of preeclampsia. It begins by outlining recommendations for blood pressure measurement in pregnancy. It then covers the classification of hypertension in pregnancy and risk factors for preeclampsia. The document discusses the etiology of preeclampsia involving poor placentation leading to placental oxidative stress and endothelial dysfunction. Predictors of preeclampsia and the role of ultrasound are described. Management involves termination of pregnancy, with timing based on gestational age and severity of symptoms. Antihypertensive therapy aims to control blood pressure without dropping it too low.
Preeclampsia in pregnancy etiopathogenesis and management Deepti Daswani
This document discusses the etiopathogenesis and management of preeclampsia. It begins by outlining recommendations for blood pressure measurement in pregnancy. It then covers the classification of hypertension in pregnancy and risk factors for preeclampsia. The document discusses the etiology of preeclampsia involving poor placentation leading to placental oxidative stress and endothelial dysfunction. Predictors of preeclampsia and the role of ultrasound are described. Management involves termination of pregnancy, with timing based on gestational age and severity of symptoms. Antihypertensive therapy aims to control blood pressure without dropping it too low.
This document discusses edema in children, including the pathophysiology, causes, evaluation, and management. It notes that edema results from an accumulation of fluid in the interstitial space and can be caused by increased hydrostatic pressure, decreased oncotic pressure, or increased capillary permeability. Common causes in children include nephrotic syndrome, heart failure, acute glomerulonephritis, renal failure, cirrhosis, and protein-energy malnutrition. The evaluation involves history, physical exam, urine analysis, and labs tailored to suspected etiology. Management focuses on sodium and fluid restriction, diuretics, and intravenous albumin as needed.
The document provides information on acute pancreatitis including:
1. It describes the types of acute pancreatitis as mild or severe and discusses the Atlanta classification system.
2. The clinical presentation, complications, pathogenesis, and investigations for acute pancreatitis are summarized. Common symptoms include severe abdominal pain while complications can include systemic effects, local pancreatic complications, or respiratory issues.
3. The document outlines the evaluation of a patient with suspected acute pancreatitis including signs on history, examination findings, and initial laboratory tests to check for signs of inflammation, organ dysfunction, or systemic effects.
The document defines various types of strokes and transient ischemic attacks. It discusses the epidemiology, risk factors, clinical features, investigations, and management of strokes. The main types are ischemic and hemorrhagic strokes. Investigations include brain imaging like CT scan and MRI to identify the type of stroke and underlying causes. Treatment focuses on minimizing brain damage, preventing complications, rehabilitation, and reducing the risk of recurrence.
The document provides an overview of several endocrine diseases and conditions that may affect the pancreas, kidneys, thyroid gland, parathyroid gland, and adrenal gland. It summarizes key pathological features of acute pancreatitis, diabetic kidney disease, thyroid disorders like Graves' disease and Hashimoto's thyroiditis, papillary carcinoma of the thyroid gland, parathyroid adenoma, and hemorrhage of the adrenal gland. Images are included to illustrate histological findings.
Similar to USMLE Step 1 Pathology review PART 2 (20)
This is a review for the USMLE Step 1 of Pathology. It contains anything you need to know for your exam in pictures, diagrams and tables. THIS IS A TWO PART SERIES, look for the second part.
USMLE Step 1 Molecular Biology and Biochemistry reviewAbril Santos
This is a review for the USMLE Step 1 exam for Molecular Biology and Biochemistry.
It contains anything you need to know for your exam in pictures, tables and diagrams.
This is a review for the USMLE Step 1 exam for Behavioral Science.
It contains anything you need to know for you exam in pictures, diagrams and tables.
USMLE Step 1 General review - AppendixAbril Santos
This document lists various medical terms and conditions. It includes:
1. Names of medical conditions, anatomical structures, cell types, stains, and imaging findings.
2. Systems covered include dermatology, infectious diseases, hematology, cardiology, pulmonary, gastrointestinal, renal, neurology, and oncology.
3. Related information provided for some terms includes associated symptoms, cell or tissue affected, and relevant clinical information.
This document provides information on common and less common organisms found at different body sites. It also lists some pathogenic organisms and their capsules. Some key points:
- Staphylococcus aureus and epidermidis are commonly found on the skin and nose, while streptococci and corynebacteria are less common.
- The oropharynx commonly contains streptococcus viridans and non-pathogenic neisseria, while the gingival crevices harbor various anaerobes.
- The colon microbiota varies from bifidobacteria and lactobacilli in babies to bacteroides, prevotella, and eubacteria in adults.
- The
The document summarizes key differences between innate and adaptive immunity. The innate immune system is non-specific, has limited diversity, lacks memory, and utilizes anatomical and chemical barriers, complement proteins, phagocytes, and natural killer cells. The adaptive immune system is specific, has high diversity, possesses memory, and relies on lymphocytes and antibodies. The document also provides an overview of hematopoiesis and the development of various immune cells from stem cell progenitors.
TV Azteca is a Mexican media company with a global presence in over 140 countries and 18 languages translated. It operates 3 channels - Red Azteca 7, Red Azteca 13, and Canal 40 - with popular shows like La Academia and Hechos del Siete. The company relies entirely on advertising revenue, dividing its programming and commercials to target different social classes and maximize ratings during prime time hours of highest viewership. As a leading media firm in Mexico, TV Azteca faces competition within the industry that it analyzes both for the country and its competitors.
Presentamos un caso clínico de un hombre de 42 años con disuria, hematuria, etc. Finalmente es diagnosticado con Litos Renales.
Incluye resultados de laboratorio y estudios de gabinete.
Presentamos un caso clínico de una mujer de 67 años con un tumor cerebral maligno de tipo Glioblastoma.
Incluye padecimiento actual, resultados de laboratorios y estudios de gabinete, y seguimiento.
Helicobacter pylori es una bacteria gram-negativa que coloniza el estómago humano y causa inflamación. Se adhiere a la mucosa gástrica a través de hemaglutininas y toxinas vacuolizantes, lo que daña el epitelio y activa el sistema inmune. La ureasa de H. pylori neutraliza el ácido gástrico, permitiendo que la bacteria sobreviva en el estómago ácido y cause inflamación a través de la liberación de amoníaco.
Descripción de los tipos de Anemia, se incluyen definiciones, tratamiento, etc.
Además incluye un caso clínico con explicación de los signos y síntomas que presenta el paciente.
Este documento describe la Taenia Solium, un parásito intestinal que puede causar cisticercosis humana. Pertenece al orden Cestoda y se desarrolla en el intestino humano. Sus especies más comunes son T. Solium e T. Saginata. T. Solium puede infectar humanos mediante la ingestión de huevos, mientras que T. Saginata causa cisticercosis bovina. El ciclo de vida involucra al cerdo como hospedador intermediario y al humano como hospedador definitivo a través de la ingestión de carne de
Brief revision of a very important ophthalmologic & pediatric tumor, includes epidemiology, classification, clinical picture, imaging studies and treatment. Also contains several photos of patients with the disease.
Neurología: Caso clínico de Neuroblastoma en mujer de la tercera edad. Incluye antecedentes, estudios de gabinete, resultados de laboratorio, conclusión y seguimiento.
La enfermedad renal crónica es la pérdida gradual de la función renal durante más de tres meses. La diabetes y la hipertensión representan más del 70% de los nuevos casos en Estados Unidos. A medida que disminuye la función renal, aumentan las complicaciones como la anemia, la hipertensión y las alteraciones cardiovasculares, óseas y metabólicas. El diagnóstico requiere pruebas de laboratorio como la química sanguínea y los niveles de parathormona, calcio y fósforo.
General anesthetics are drugs that induce reversible loss of consciousness and sensations during surgery. They work by depressing the central nervous system in stages, starting with cortical centers and ending with the medulla. There are two main types - inhalational gases administered through masks or intravenous drugs given through injections. A balanced anesthesia approach uses multiple drugs to induce unconsciousness, amnesia, analgesia, and muscle relaxation. Precise drug combinations and dosages are tailored for each patient and procedure type. The goal is to smoothly induce and rapidly recover from anesthesia with minimized risks and side effects.
La dermatitis por contacto es un síndrome causado por la aplicación de una sustancia en la piel. Puede ser aguda o crónica. Se origina por irritantes primarios o por sensibilización. Los síntomas incluyen eritema, vesículas, liquenificación y descamación. El diagnóstico se basa en la historia clínica y pruebas de parche. El tratamiento consiste en identificar y evitar la sustancia causal, y el uso de pomadas y antihistamínicos para aliviar los síntomas.
low birth weight presentation. Low birth weight (LBW) infant is defined as the one whose birth weight is less than 2500g irrespective of their gestational age. Premature birth and low birth weight(LBW) is still a serious problem in newborn. Causing high morbidity and mortality rate worldwide. The nursing care provide to low birth weight babies is crucial in promoting their overall health and development. Through careful assessment, diagnosis,, planning, and evaluation plays a vital role in ensuring these vulnerable infants receive the specialize care they need. In India every third of the infant weight less than 2500g.
Birth period, socioeconomical status, nutritional and intrauterine environment are the factors influencing low birth weight
The skin is the largest organ and its health plays a vital role among the other sense organs. The skin concerns like acne breakout, psoriasis, or anything similar along the lines, finding a qualified and experienced dermatologist becomes paramount.
Summer is a time for fun in the sun, but the heat and humidity can also wreak havoc on your skin. From itchy rashes to unwanted pigmentation, several skin conditions become more prevalent during these warmer months.
Cell Therapy Expansion and Challenges in Autoimmune DiseaseHealth Advances
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
Breast cancer: Post menopausal endocrine therapyDr. Sumit KUMAR
Breast cancer in postmenopausal women with hormone receptor-positive (HR+) status is a common and complex condition that necessitates a multifaceted approach to management. HR+ breast cancer means that the cancer cells grow in response to hormones such as estrogen and progesterone. This subtype is prevalent among postmenopausal women and typically exhibits a more indolent course compared to other forms of breast cancer, which allows for a variety of treatment options.
Diagnosis and Staging
The diagnosis of HR+ breast cancer begins with clinical evaluation, imaging, and biopsy. Imaging modalities such as mammography, ultrasound, and MRI help in assessing the extent of the disease. Histopathological examination and immunohistochemical staining of the biopsy sample confirm the diagnosis and hormone receptor status by identifying the presence of estrogen receptors (ER) and progesterone receptors (PR) on the tumor cells.
Staging involves determining the size of the tumor (T), the involvement of regional lymph nodes (N), and the presence of distant metastasis (M). The American Joint Committee on Cancer (AJCC) staging system is commonly used. Accurate staging is critical as it guides treatment decisions.
Treatment Options
Endocrine Therapy
Endocrine therapy is the cornerstone of treatment for HR+ breast cancer in postmenopausal women. The primary goal is to reduce the levels of estrogen or block its effects on cancer cells. Commonly used agents include:
Selective Estrogen Receptor Modulators (SERMs): Tamoxifen is a SERM that binds to estrogen receptors, blocking estrogen from stimulating breast cancer cells. It is effective but may have side effects such as increased risk of endometrial cancer and thromboembolic events.
Aromatase Inhibitors (AIs): These drugs, including anastrozole, letrozole, and exemestane, lower estrogen levels by inhibiting the aromatase enzyme, which converts androgens to estrogen in peripheral tissues. AIs are generally preferred in postmenopausal women due to their efficacy and safety profile compared to tamoxifen.
Selective Estrogen Receptor Downregulators (SERDs): Fulvestrant is a SERD that degrades estrogen receptors and is used in cases where resistance to other endocrine therapies develops.
Combination Therapies
Combining endocrine therapy with other treatments enhances efficacy. Examples include:
Endocrine Therapy with CDK4/6 Inhibitors: Palbociclib, ribociclib, and abemaciclib are CDK4/6 inhibitors that, when combined with endocrine therapy, significantly improve progression-free survival in advanced HR+ breast cancer.
Endocrine Therapy with mTOR Inhibitors: Everolimus, an mTOR inhibitor, can be added to endocrine therapy for patients who have developed resistance to aromatase inhibitors.
Chemotherapy
Chemotherapy is generally reserved for patients with high-risk features, such as large tumor size, high-grade histology, or extensive lymph node involvement. Regimens often include anthracyclines and taxanes.
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdfRahul Sen
Time-lapse embryo monitoring is an advanced imaging technique used in IVF to continuously observe embryo development. It captures high-resolution images at regular intervals, allowing embryologists to select the most viable embryos for transfer based on detailed growth patterns. This technology enhances embryo selection, potentially increasing pregnancy success rates.
These lecture slides, by Dr Sidra Arshad, offer a simplified look into the mechanisms involved in the regulation of respiration:
Learning objectives:
1. Describe the organisation of respiratory center
2. Describe the nervous control of inspiration and respiratory rhythm
3. Describe the functions of the dorsal and respiratory groups of neurons
4. Describe the influences of the Pneumotaxic and Apneustic centers
5. Explain the role of Hering-Breur inflation reflex in regulation of inspiration
6. Explain the role of central chemoreceptors in regulation of respiration
7. Explain the role of peripheral chemoreceptors in regulation of respiration
8. Explain the regulation of respiration during exercise
9. Integrate the respiratory regulatory mechanisms
10. Describe the Cheyne-Stokes breathing
Study Resources:
1. Chapter 42, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 36, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 13, Human Physiology by Lauralee Sherwood, 9th edition
DECLARATION OF HELSINKI - History and principlesanaghabharat01
This SlideShare presentation provides a comprehensive overview of the Declaration of Helsinki, a foundational document outlining ethical guidelines for conducting medical research involving human subjects.
10 Benefits an EPCR Software should Bring to EMS Organizations Traumasoft LLC
The benefits of an ePCR solution should extend to the whole EMS organization, not just certain groups of people or certain departments. It should provide more than just a form for entering and a database for storing information. It should also include a workflow of how information is communicated, used and stored across the entire organization.
Know the difference between Endodontics and Orthodontics.Gokuldas Hospital
Your smile is beautiful.
Let’s be honest. Maintaining that beautiful smile is not an easy task. It is more than brushing and flossing. Sometimes, you might encounter dental issues that need special dental care. These issues can range anywhere from misalignment of the jaw to pain in the root of teeth.
3. For it to be an aortic
dissection you need 2
things:
1. Pre-existing weakness
of the media
(Hypertension or
inherited defects)
2. Occurs in the
proximal 10 cms of
the aorta
Complications:
Pericardial tamponade,
rupture or vessel
obstruction.
4. Aortic Insufficiency or Embolism
-Pulsatile mass that
grows with time
Major complication is
rupture when >5cms in
diameter.
When rupture:
-Hypotension
-Pulsatile abdominal
mass
-Flank pain
5. STABLE ANGINA
Chest pain (<20 mins)
Pain relieved with rest or Nitroglycerin
EKG: ST segment depression
(subendocardial ischemia)
UNSTABLE ANGINA
Chest pain occurs at rest
Rupture of atherosclerotic plaque –
incomplete occlusion of coronary artery.
EKG: ST segment depression
Pain relieved with Nitroglycerin
PRINZMETAL ANGINA
Coronary artery vasospasm
EKG: ST segment elevation (transmural)
MYOCARDIAL INFARCTION
Necrosis of cardiac myocytes.
Rupture of atherosclerotic plaque –
complete occlusion of coronary artery.
Occlusion for >20 mins (vasospasm or
vasculitis - Kawasaki).
Symptoms not relieved by Nitroglycerin
Most common involved:
Left Anterior Descending (1st) Anterior
LV
Right Coronary (2nd) Posterior LV
Left circumflex (3rd) Lateral LV
EPI
MYO
ENDO 1st ST segment depression
2nd ST segment elevation
10. ENDOCARDITIS
Inflammation of the endocardium that
lines the surface of the valves.
Most commonly due to bacterial
infection
S. Viridans - Infects previously damaged
valves.
S. Aureus – IV drug abuse, infects normal
valves. (Tricuspid)
S. Epidermidis – Endocarditis of
prosthetic valves.
S. Bovis – Patient with underlying
colorectal carcinoma
HACEK organisms – Negative blood
cultures
11. DILATED CARDIOMYOPATHY
• All four chambers dilated
• MOST COMMON FORM
• Systolic dysfunction
• Biventricular CHF
• Idiopathic
TX: Transplant
HYPERTROPHIC CARDIOMYOPATHY
• LV massive hypertrophy
• Mutations in the sarcomere
proteins (Autosomal D)
• Diastolic dysfunction
• Decreased cardiac output
• Sudden death
RESTRICTIVE CARDIOMYOPATHY
• Decreased compliance of
ventricular endocardium
• Restricts filling during
diastole
Causes: Amyloidosis, sarcoidosis,
Hemocromatosis, fibroelastosis,
Loeffler syndrome
16. EMPHYSEMA
Smokers
1. Most common cause
2. Pollutants cause excessive protease damage
3. Centriacinar emphysema
4. Severe in the upper lobes
Alpha-1 Antitrypsin Deficiency
1. Rare cause
2. Lack of antiprotease causes vulnerability
3. Panacinar emphysema
4. Sever in lower lobes
5. Liver cirrhosis may be present
18. L/S Ratio Lecithin Sphingomyelin
3
2
1
MATURE
TRANSITIONAL
IMMATURE
20 25 30 35 40Gestational Age
(Weeks)
19. Lung Carcinoma
Metastasis
Cannon-ball nodules
More common than
primary tumors
Small Cell
Carcinoma
Poorly
differentiated
From Kulchitsky
cells
Chromogranin
positive
Non-Small Cell
Carcinoma (85%)
Adenocarcinoma
(40%)
Glands and mucus
production
Most common in
non-smokers
Squamous Cell
Carcinoma (30%)
Keratin pearls,
intercellular bridges
Most common in
males
Large Cell
Carcinoma (10%)
All negative
Poor prognosis
Carcinoid tumor
(5%)
Chromogranin
Positive
Polyp-like mass
Bronchioloalveolar
Carcinoma
Arises from Clara
cells
Pneumonia-like
Consolidation
22. L M SM MP S
Lumen
Mucosa
Submucosa
Muscularis propria
Serosa
Inter-circular Layer
Outer-longitudinal Layer
Myenteric Plexus
Meissner Plexus
IC OL
MyP
GI EPITHELIUM
Achalasia
Esophageal Web
Mallory-Weiss
Esophageal Varices
MeP
Ulcerative Colitis
Crohn Disease
Hirschsprung Disease
23. 2% population
2 years old
2 inches long
Within 2 feet of ileocecal valve
Colonic Diverticula
30. Skin Flushing
Cyanosis
Carcinoid Heart Disease
Right-side valvular fibrosis
Diarrhea
Cramps
Nausea
Vomiting
Bronchospasm
Cough
Wheezing
Starts with Metastasis
Hepatomegaly
Small Bowel
MOST COMMON
location
CARCINOID SYNDROME
31. RISK FOR PROGRESSION
1. > 2 cm
2. Sessile growth
3. Villous Histology
P53 Mutation
Elevated COX
(Aspirin is protective)
32. Dorsal Bud:
Lower part of the
head and
uncinated
process
Ventral Bud:
Upper part of
the head, neck,
body and tail
33. Pale feces due to
blockage of bile
Bile leaks out into the
vessel and gives
jaundice.
Palpable gallbladder
PANCREATIC
CARCINOMA
Marker:
CA 19-9
Whipple procedure
37. Liver infarction secondary
to hepatic vein obstruction
Painful hepatomegaly and
ascites
1. Thrombi
2. Hepatocellular
carcinoma
38. Conjoined kidneys
usually connected at
lower pole
Most common
congenital anomaly.
Horseshoe Kidney Renal Agenesis Dysplastic Kidney Polycystic Kidney
DiseaseInferior
Mesenteric A
Kidney absence, may be
unilateral or bilateral.
Unilateral: Kidney
undergoes hypertrophy,
may lead to renal failure
Bilateral: Potter sequence
Non-inherited
malformation of renal
parenchyma with cysts
and abnormal tissue
(cartilage)
May be bilateral
Inherited defect, bilateral
enlarged kidneys with
cysts in renal cortex and
medulla, associated with
Portal HTN.
May have Potter sequence
AR vs AD(ult)
39. Pre-Renal Azotemia
Blood flow blockage
BUN:Creatinine >20
Decreased GFR
FENa <1%
Post-Renal Azotemia
Outflow blockage
BUN:Creatinine >15
Decreased GFR
FENa <1%
Intra-Renal Azotemia
1. Causes: Acute Tubular Necrosis (most
common cause of ARF) Muddy brown casts in
urine
2. Acute Interstitial Nephritis
3. Renal Papillary Necrosis
BUN:Creatinine <15
FENa >2%, Decreased GFR
Urine osmolarity <500
Long standing obstruction
BUN:Creatinine <15
FENa >2%
Urine osmolarity <500
40. NEPHROTIC SYNDROME NEPHRITIC SYNDROME
Proteinuria (>3.5 g/day)
Hypoalbuminemia Edema.
Hypogammaglobulinemia risk of infections
Hypercoagulable state lose Antithrombin III
Hyperlipidemia and Hypercholesterolemia
1. Minimal Change Disease (associated with
Hodgkin Lymphoma)
2. Focal Segmental Glomerulosclerosis
(associated with HIV, Heroin or sickle cell)
3. Membranous Nephropathy (associated with
Hepatitis, solid tumors, SLE or drugs)
Subepithelial deposits, Dome and Spike
4. Membranoproliferative
Glomerulonephritis Type I subendothelial,
associated with HBV/HCV. Tram-track
appearance
Type II intramembranous, C3 nephritic factor
5. Diabetes Mellitus (sclerosis of the mesangium)
6. Systemic Amyloidosis (amyloid deposits)
Limited Proteinuria <3.5 g/day
Oliguria and azotemia
Salt Retention periorbital edema and HTN
RBC casts and dysmorphic RBC in urine
C5a Deposits causes swelling
1. Post-streptococcal Glomerulonephritis
(associated with M protein factor)
2. Rapidly Progressive Glomerulonephritis
(crescents comprised of fibrin and macrophages)
1. Linear Goodpasture syndrome
2. Granular PSGN (most common), Diffuse
proliferative GN (SLE most common)
3. Negative IF Wegener granulomatosis (c-
ANCA) Churg-Strauss (p-ANCA)
3. IgA nephropathy (Berger disease) deposits
in the mesangium of glomeruli with infections
4. Alport Syndrome defect in type IV collagen,
splitting of glomerular BM
41. Renal Cell
Carcinoma
• Classic Triad: Hematuria, Flank
pain and palpable mass
Paraneoplastic syndromes:
1. EPO: Reactive Polycythemia
2. Renin: Hypertension
3. PTHrP: Hypercalcemia
4. ACTH: Cushing Syndrome
May present LEFT-sided varicocele.
Most common is CLEAR CELL type
Loss of VHL, increased HIF factor
42.
43. ADENOSIS
Persistent Mullerian columnar
epithelium in the anterior wall
and upper 1/3 of vagina.
After DES (diethylstilbestrol)
exposure – used for prevention
of pregnancy complications.
May lead to Clear Cell
adenocarcinoma.
52. Exogenous Corticosteroids
(Most common)
Cortisol goes to anterior pituitary and
shuts down ACTH
Both glands are atrophic
Primary adenoma, hyperplasia or
Adrenal Carcinoma.
One gland produces excess cortisol,
will shut down ACTH and affect the
other gland.
ACTH-secreting Pituitary Adenoma
Excess ACTH will hit both adrenals
making them BIG and produce
excess Cortisol
High-dose Dexamethasone will
SUPRESS ACTH production.
Paraneoplastic ACTH secretion
A tumor secreting ACTH (small cell
carcinoma) will hit both adrenals,
making them BIG and produce
cortisol